ADAM 10 is associated with gastric cancer progression and prognosis of patients

ADAM10 as a Therapeutic Target for Cancer and Inflammation

(2009) Howard Crawford et al.   CURRENT PHARMACEUTICAL DESIGN

MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib

(2009) Shoumei Bai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Anti-ERBB2 sh-RNA Suppress Both Cell Growth and Tumor Growth in ERBB2-Overexpressing Upper Gastrointestinal Adenocarcinomas

(2009) Amanda K. Arrington et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Clinicopathological Characteristics and Predictive Markers of Early Gastric Cancer with Recurrence

(2009) Jeong Won Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas

(2009) Amanda K. Arrington et al.   SURGERY

Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor

(2008) L. Witters et al.   CANCER RESEARCH